Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Cardiovascular Disease Drugs Market Research Reports
Cardiovascular Disease Drugs Market Research Reports
| Title | published | price | |
|---|---|---|---|
Venous (Vein) Thrombosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... peline landscape.
The report provides comprehensive information on the therapeutics under development for Venous (Vein) Thrombosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administ......" | 02-May-2022 | $2000 | |
Venous Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... landscape.
The report provides comprehensive information on the therapeutics under development for Venous Thromboembolism, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (......" | 02-May-2022 | $2000 | |
Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... es comprehensive information on the therapeutics under development for Ischemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descr......" | 02-May-2022 | $2000 | |
Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... landscape.
The report provides comprehensive information on the therapeutics under development for Resistant Hypertension, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (......" | 02-May-2022 | $2000 | |
Chronic Thromboembolic Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... verview of the Chronic Thromboembolic Pulmonary Hypertension pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chronic Thromboembolic Pulmonary Hypertension, complete with analysi......" | 02-May-2022 | $2000 | |
Ischemic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ine landscape.
The report provides comprehensive information on the therapeutics under development for Ischemic Cardiomyopathy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 02-May-2022 | $2000 | |
Acute Coronary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ine landscape.
The report provides comprehensive information on the therapeutics under development for Acute Coronary Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 02-May-2022 | $2000 | |
Acute Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... e.
The report provides comprehensive information on the therapeutics under development for Acute Heart Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Mol......" | 02-May-2022 | $2000 | |
Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... landscape.
The report provides comprehensive information on the therapeutics under development for Systolic Heart Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (......" | 02-May-2022 | $2000 | |
Carotid Artery Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ine landscape.
The report provides comprehensive information on the therapeutics under development for Carotid Artery Stenosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 02-May-2022 | $2000 | |
| | |||